Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

MANÜ Telehealth vs NuBloom

MANÜ Telehealth
Graded #86

Higher grade

vs+3
NuBloom
Graded #137

Lower grade

The verdict

MANÜ Telehealth takes it — 72/100 to 69/100.

MANÜ Telehealth grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. MANÜ Telehealth is a US online platform offering compounded GLP-1 weight loss medication including injectable tirzepatide and semaglutide, with add-ons like MIC Ultraburn and NAD+ injections.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueMANÜ Telehealth +12
84
72
Dose & formulationMANÜ Telehealth +10
64
54
Clinical oversightNuBloom +3
79
82
Labs & monitoringMANÜ Telehealth +2
63
61
FulfillmentNuBloom +14
71
85
Contract termsEven
55
55
MANÜ Telehealth · left barNuBloom · right bar

The numbers

MetricMANÜ TelehealthNuBloom
WeighScore72/10069/100
GradeCC
Scorecard rank#86#137
Semaglutide$120/mo (compounded)$149/mo (2.4 mg dose, compounded)
Tirzepatide$150/mo (compounded)$279/mo (15 mg dose, compounded)
CoverageCoverage not published49 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
MANÜ Telehealth

Graded #86 · C

Strengths

  • Compounded GLP-1s advertised from about $4-$5/day
  • 100% online with free discreet shipping and no insurance needed
  • Compounds exclusively from US 503A pharmacies
  • Add-on options like MIC Ultraburn and NAD+

Where it loses points

  • Per-dose pricing is gated behind login/signup, not public
  • State availability changes and is only confirmed at signup
  • Compounded medications are not FDA-evaluated
NuBloom

Graded #137 · C

Strengths

  • Transparent, openly published pricing: compounded semaglutide $149/mo and tirzepatide $279/mo as flexible month-to-month subscriptions
  • Founded and medically led by a named physician (Dr. Marianne Pinkston Mueller, family/integrative medicine, 25+ years)
  • Whole-person model pairs GLP-1s with hormone, gut-health and longevity care plus in-depth lab testing
  • State coverage published openly: 49 states listed on the site (all except Mississippi)
  • Optional 90-day 1:1 coaching program with weekly meetings and unlimited text support ($599/mo)

Where it loses points

  • Compounding pharmacy partners are not named anywhere on the site — a transparency gap
  • NuBloom's own LegitScript/PCAB status is not displayed; only its telehealth partner is certified
  • Compounded medications are not FDA-approved; one FAQ loosely calls them 'FDA-approved,' contradicting the product pages
  • All sales are final and medical consult fees are non-refundable; no returns on prescription products
  • Disputes go to binding individual arbitration; the Terms' governing-law state is left as an unfilled '[STATE]' placeholder

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard